Stockreport

Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®

Axogen, Inc.  (AXGN) 
Last axogen, inc. earnings: 2/24 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.axogeninc.com
PDF ALACHUA, Fla. and TAMPA, Fla., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solution [Read more]